These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26058033)

  • 1. Eye platelet-rich plasma in the treatment of ocular surface disorders.
    Alio JL; Rodriguez AE; WróbelDudzińska D
    Curr Opin Ophthalmol; 2015 Jul; 26(4):325-32. PubMed ID: 26058033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of "eye platelet rich plasma" (E-PRP) for wound healing in ophthalmology.
    Alio JL; Arnalich-Montiel F; Rodriguez AE
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1257-65. PubMed ID: 21740369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study.
    Alio JL; Rodriguez AE; Martinez LM; Rio AL
    JAMA Ophthalmol; 2013 Jun; 131(6):745-51. PubMed ID: 23559361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop.
    Anitua E; Muruzabal F; De la Fuente M; Merayo-Lloves J; Orive G
    Exp Eye Res; 2014 Feb; 119():27-34. PubMed ID: 24345372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine pericardium membrane (tutopatch) combined with solid platelet-rich plasma for the management of perforated corneal ulcers.
    Alio JL; Rodriguez AE; Martinez LM
    Cornea; 2013 May; 32(5):619-24. PubMed ID: 22929158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid Platelet Rich Plasma in Corneal Surgery.
    Arnalich F; Rodriguez AE; Luque-Rio A; Alio JL
    Ophthalmol Ther; 2016 Jun; 5(1):31-45. PubMed ID: 27179661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.
    Anitua E; de la Fuente M; Muruzabal F; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2015 Jun; 135():118-26. PubMed ID: 25708868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers.
    Alio JL; Abad M; Artola A; Rodriguez-Prats JL; Pastor S; Ruiz-Colecha J
    Ophthalmology; 2007 Jul; 114(7):1286-1293.e1. PubMed ID: 17324465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood derived eye drops for the treatment of cornea and ocular surface diseases.
    Giannaccare G; Versura P; Buzzi M; Primavera L; Pellegrini M; Campos EC
    Transfus Apher Sci; 2017 Aug; 56(4):595-604. PubMed ID: 28844373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis.
    Kim KM; Shin YT; Kim HK
    Jpn J Ophthalmol; 2012 Nov; 56(6):544-50. PubMed ID: 22972393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-rich plasma, the ultimate secret for youthful skin elixir and hair growth triggering.
    Elghblawi E
    J Cosmet Dermatol; 2018 Jun; 17(3):423-430. PubMed ID: 28887865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-derived topical therapy for ocular surface diseases.
    Soni NG; Jeng BH
    Br J Ophthalmol; 2016 Jan; 100(1):22-7. PubMed ID: 26178904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Use of Highly Concentrated Autologous Platelet-Rich Plasma and Platelet-Rich Fibrin Membrane to Improve the Outcome in the Management of Severe Dry Eye Disease, Corneal Neurotrophic Ulcer and Corneal Burn.
    Hassan A; Telandro A; Barguigua A; Baba M; Körber N
    Cureus; 2024 Jan; 16(1):e51794. PubMed ID: 38322082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological effects of stored platelet-rich plasma eye-drops in corneal wound healing.
    Okumura Y; Inomata T; Fujimoto K; Fujio K; Zhu J; Yanagawa A; Shokirova H; Saita Y; Kobayashi Y; Nagao M; Nishio H; Sung J; Midorikawa-Inomata A; Eguchi A; Nagino K; Akasaki Y; Hirosawa K; Huang T; Kuwahara M; Murakami A
    Br J Ophthalmol; 2023 Dec; 108(1):37-44. PubMed ID: 36162968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction.
    Chiou AG; Florakis GJ; Kazim M
    Surv Ophthalmol; 1998; 43(1):19-46. PubMed ID: 9716191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical amniotic fluid: a potential new alternative for ocular surface diseases].
    Quinto GG; Martins SA; Tiemi R; Campos M; Behrens A
    Arq Bras Oftalmol; 2008; 71(6 Suppl):55-60. PubMed ID: 19274412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances and prospects of platelet-rich plasma therapy in veterinary ophthalmology.
    Sharun K; Chandran D; Manjusha KM; Mankuzhy PD; Kumar R; Pawde AM; Dhama K; El-Husseiny HM; Amarpal
    Vet Res Commun; 2023 Sep; 47(3):1031-1045. PubMed ID: 36607500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases.
    Anitua E; Muruzabal F; de la Fuente M; Merayo J; Durán J; Orive G
    Curr Eye Res; 2016 Jul; 41(7):875-82. PubMed ID: 26828610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells.
    Anitua E; de la Fuente M; Sánchez-Ávila RM; de la Sen-Corcuera B; Merayo-Lloves J; Muruzábal F
    Curr Eye Res; 2023 May; 48(5):456-464. PubMed ID: 36695530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-conjugated poly(lactic-co-glycolic acid) nanospheres enhance large-wound healing by delivering growth factors in platelet-rich plasma.
    La WG; Yang HS
    Artif Organs; 2015 Apr; 39(4):388-94. PubMed ID: 25284020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.